Continue to site >
Trending ETFs

Name

As of 05/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$8.17

$916 M

0.00%

0.86%

Vitals

YTD Return

16.5%

1 yr return

52.1%

3 Yr Avg Return

-41.8%

5 Yr Avg Return

N/A

Net Assets

$916 M

Holdings in Top 10

33.7%

52 WEEK LOW AND HIGH

$8.1
$4.82
$11.26

Expenses

OPERATING FEES

Expense Ratio 0.86%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 05/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$8.17

$916 M

0.00%

0.86%

MSOS - Profile

Distributions

  • YTD Total Return 16.5%
  • 3 Yr Annualized Total Return -41.8%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.49%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    AdvisorShares Pure US Cannabis ETF
  • Fund Family Name
    AdvisorShares
  • Inception Date
    Sep 01, 2020
  • Shares Outstanding
    49525000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Dan Ahrens

Fund Description

The Fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. The Fund primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The Fund also may invest in micro-capitalization companies.

In addition to its investment in securities of companies that derive a significant portion of their revenue from the marijuana and hemp business, and in derivatives providing exposure to such securities, the Fund may invest in securities of companies that, in the opinion of the Advisor, may have current or future revenues from cannabis-related business or that are registered with the Drug Enforcement Administration (“DEA”) specifically for the purpose of handling marijuana for lawful research and development of cannabis or cannabinoid-related products.

Cannabis securities may be categorized among a wide variety of sectors and industries including agriculture, biotechnology, pharmaceuticals, real estate, retail, and finance. The types of companies that may engage in cannabis-related business include companies that conduct medical research, produce drug products, manufacture hemp products, or engage in agricultural activities, real estate activities, or financial services activities. The terms “marijuana” and “cannabis” are used interchangeably. Hemp refers to the industrial/commercial use of the cannabis stalk and seed for textiles, foods, papers, body care products, detergents, plastics and building materials. Cannabinoids are the chemical compounds secreted by cannabis plants. Cannabinoids can also be synthetically produced chemical compounds and used in lawful research and development of prescription drugs or other products utilizing cannabinoids as an active ingredient. The Advisor believes that continued legislative changes and social acceptance of cannabis in its various formats could lead to significant growth in cannabis-related public corporations. Companies involved in cannabis-related business could also benefit from significant merger and acquisition activity as the cannabis market matures. The Fund will not invest directly in or hold ownership in any companies that engage in cannabis-related business unless permitted by national and local laws of the relevant jurisdiction, including U.S. federal and state laws.

The Fund will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The Fund is non-diversified and may invest a greater percentage of its assets in a particular issuer than a diversified fund.

The Advisor may use a variety of methods for security selection. As the Fund primarily focuses on certain industries, the Advisor intends to select companies with dominant positions in their respective markets, or those in unique positions for growth and expansion. The Advisor will utilize numerous outside analyst ratings and stock selection rating tools. In addition, the Advisor may invest the Fund’s assets in lesser-known companies that the Advisor believes have a unique opportunity for growth. At times, the Advisor may aim to buy certain out-of-favor stocks believed to be at prices below their future potential value, as measured by the Advisor or outside analysts. The Fund may sell a security when the Advisor believes that the security is overvalued or better investment opportunities are available, or to limit position size within the Fund’s portfolio.

Read More

MSOS - Performance

Return Ranking - Trailing

Period MSOS Return Category Return Low Category Return High Rank in Category (%)
YTD 16.5% -23.0% 100.1% 20.00%
1 Yr 52.1% -36.0% 91.9% 17.14%
3 Yr -41.8%* -42.1% 20.2% 94.12%
5 Yr N/A* -29.3% 23.7% 73.53%
10 Yr N/A* -1.3% 13.8% 68.97%

* Annualized

Return Ranking - Calendar

Period MSOS Return Category Return Low Category Return High Rank in Category (%)
2023 0.3% -34.8% 38.7% 54.29%
2022 -72.7% -72.7% 8.2% 100.00%
2021 -29.9% -31.7% 27.4% 93.94%
2020 N/A -29.0% 233.6% N/A
2019 N/A -2.0% 66.0% N/A

Total Return Ranking - Trailing

Period MSOS Return Category Return Low Category Return High Rank in Category (%)
YTD 16.5% -23.0% 100.1% 20.00%
1 Yr 52.1% -36.0% 91.9% 17.14%
3 Yr -41.8%* -42.1% 20.2% 94.12%
5 Yr N/A* -29.3% 23.7% N/A
10 Yr N/A* -1.3% 13.8% N/A

* Annualized

Total Return Ranking - Calendar

Period MSOS Return Category Return Low Category Return High Rank in Category (%)
2023 0.3% -33.0% 39.0% 57.14%
2022 -72.7% -72.7% 8.2% 100.00%
2021 -29.7% -31.7% 28.3% 93.94%
2020 N/A -28.9% 233.9% N/A
2019 N/A 0.4% 66.5% N/A

MSOS - Holdings

Concentration Analysis

MSOS Category Low Category High MSOS % Rank
Net Assets 916 M 3.65 M 31.2 B 34.29%
Number of Holdings 47 20 389 54.29%
Net Assets in Top 10 366 M 2.2 M 5.86 B 31.43%
Weighting of Top 10 33.65% 11.8% 90.5% 77.14%

Top 10 Holdings

  1. BLACKROCK TREASURY TRUST 14.13%
  2. Curaleaf Holdings Inc 4.59%
  3. TerrAscend Corp 3.76%
  4. TRS TRULIEVE CANNABIS CORPORATION 3.64%
  5. TRS GREEN THUMB INDUSTRIES 3.19%
  6. TRS VERANO HOLDINGS CORP 1.53%
  7. TRS CURALEAF HOLDINGS 1.33%
  8. TRS CRESCO LABS 0.81%
  9. TRS AYR WELLNESS INC 0.33%
  10. TRS TRULIEVE CANNABIS 0.32%

Asset Allocation

Weighting Return Low Return High MSOS % Rank
Cash
78.91% 0.00% 78.91% 2.86%
Other
12.70% -0.20% 91.95% 17.14%
Stocks
8.38% 0.00% 99.95% 88.57%
Preferred Stocks
0.00% 0.00% 44.60% 80.00%
Convertible Bonds
0.00% 0.00% 3.05% 79.41%
Bonds
0.00% 0.00% 95.99% 77.14%

Stock Sector Breakdown

Weighting Return Low Return High MSOS % Rank
Utilities
0.00% 0.00% 85.14% 86.15%
Technology
0.00% 0.00% 72.56% 95.38%
Real Estate
0.00% 0.00% 16.54% 3.08%
Industrials
0.00% 0.00% 90.47% 24.62%
Healthcare
0.00% 0.00% 65.82% 29.23%
Financial Services
0.00% 0.00% 95.51% 84.62%
Energy
0.00% 0.00% 32.10% 83.08%
Communication Services
0.00% 0.00% 16.38% 87.69%
Consumer Defense
0.00% 0.00% 50.44% 87.69%
Consumer Cyclical
0.00% 0.00% 34.19% 21.54%
Basic Materials
0.00% 0.00% 17.92% 93.85%

Stock Geographic Breakdown

Weighting Return Low Return High MSOS % Rank
US
8.36% 0.00% 99.93% 88.57%
Non US
0.03% 0.00% 82.54% 71.43%

MSOS - Expenses

Operational Fees

MSOS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.86% 0.41% 5.61% 48.57%
Management Fee 0.60% 0.25% 1.90% 51.43%
12b-1 Fee 0.00% 0.00% 1.00% 50.00%
Administrative Fee 0.03% 0.03% 0.19% 33.33%

Sales Fees

MSOS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 4.25% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

MSOS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

MSOS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 124.00% N/A

MSOS - Distributions

Dividend Yield Analysis

MSOS Category Low Category High MSOS % Rank
Dividend Yield 0.00% 0.00% 12.45% 91.43%

Dividend Distribution Analysis

MSOS Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annual Quarterly Quarterly

Net Income Ratio Analysis

MSOS Category Low Category High MSOS % Rank
Net Income Ratio -0.49% -2.66% 5.19% 77.14%

Capital Gain Distribution Analysis

MSOS Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

MSOS - Fund Manager Analysis

Managers

Dan Ahrens


Start Date

Tenure

Tenure Rank

Sep 01, 2020

1.75

1.8%

Dan Ahrens is a Managing Director and the Chief Operating Officer of AdvisorShares Investments, LLC. He joined the Advisor in 2008. Prior to joining the firm, Mr. Ahrens founded Ahrens Advisors, L.P., an SEC-registered investment advisor. Before forming Ahrens Advisors, he was President of the MUTUALS.com Funds. During that time he also was President and Chief Compliance Officer of Mutuals Advisors, Inc. and acted as President, Treasurer and Financial & Operations Officer of an affiliated Broker Dealer firm. He is the author of Investing in Vice (St. Martin’s Press, 2004) and has appeared on numerous financial programs, including CNBC, CNN, ABC News and Bloomberg, to discuss “Vice Stocks.” He has been featured, along with funds under his management, in major national and trade publications including The Economist, New York Times, Financial Times, and The Wall Street Journal. He earned a Bachelor in Business Administration in Finance from Texas Tech University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.75 23.1 8.85 1.25